DIGICORE welcomes the launching of Europe’s Beating Cancer Plan presented by the EC on 3 February 2021.
ABOUT THIS INITIATIVE
Today, Europe accounts for a tenth of the world’s population, but a quarter of the world’s cancer cases. In 2020, 2.7 million people in the European Union were diagnosed with cancer, and another 1.3 million die from it. Without reversing current trends, it could become the leading cause of death in the EU. With cutting-edge technologies, research and innovation as the starting point, the Cancer Plan is the EU’s response to this worrying scenario. The Plan aims to tackle the entire disease pathway and sets out a new EU approach to cancer prevention, treatment and care. It will address cancer related inequalities between and within Member States with concrete, ambitious actions to support, coordinate and complement Member States’ efforts.
Communication from the Commission to the European
Parliament and the Council Europe’s Beating Cancer Plan
COM(2021) 44 final
Europe’s Beating Cancer Plan, a key pillar of a stronger European Health Union, is designed around four key action
Ten flagship initiatives and multiple supporting action will ensure a stronger European Health Union, with a total of €4 billion being earmarked for substantive actions geared way towards a more sustainable cancer pathway. The plan taps into the potential that digitalisation, progress and new technologies offer to enable expertise and resources to be shared across the EU. It will support countries, regions and cities with less knowledge and capacity, and it will facilitate exchanging findings between small and large Member States. It will help medical staff have access to a wealth of shared information and crucial health data on the potential causes of cancer and promising treatments for it.
The plan sets significant European-wide goals and its successful implementation builds on engaging and communicating with the wider public to support our joint efforts. Recognising the value of partnerships, the Cancer Plan is based on a ‘Health in All Policies’ multi-stakeholder approach and is the result of an extensive consultation process. It reflects the views of stakeholder groups and patients, the European Parliament and Member States.